This MEDS PE ratio history page last updated 11/8/2022
Period | Price | GAAP | TTM | PE |
Q3 2022 11/7/2022 | 0.83 | -0.06 | -0.41 | NA | Q2 2022 7/25/2022 | 1.74 | -0.13 | -0.51 | NA | Q1 2022 5/9/2022 | 1.56 | -0.12 | -0.55 | NA | Q4 2021 3/28/2022 | 2.34 | -0.10 | -0.51 | NA | Q3 2021 10/25/2021 | 4.19 | -0.16 | -0.62 | NA | Q2 2021 7/26/2021 | 5.26 | -0.17 | -0.44 | NA | Q1 2021 4/26/2021 | 4.87 | -0.08 | -0.34 | NA | Q4 2020 3/29/2021 | 7.15 | -0.21 | -0.24 | NA | Q3 2020 10/26/2020 | 6.20 | 0.02 | NA | NA | Q2 2020 7/27/2020 | 6.28 | -0.07 | NA | NA | Q1 2020 5/4/2020 | 7.58 | 0.02 | NA | NA |
|
Period | Price | GAAP | Annualized | PE |
Q3 2022 11/7/2022 | 0.83 | -0.06 | -0.24 | NA | Q2 2022 7/25/2022 | 1.74 | -0.13 | -0.52 | NA | Q1 2022 5/9/2022 | 1.56 | -0.12 | -0.48 | NA | Q4 2021 3/28/2022 | 2.34 | -0.10 | -0.40 | NA | Q3 2021 10/25/2021 | 4.19 | -0.16 | -0.64 | NA | Q2 2021 7/26/2021 | 5.26 | -0.17 | -0.68 | NA | Q1 2021 4/26/2021 | 4.87 | -0.08 | -0.32 | NA | Q4 2020 3/29/2021 | 7.15 | -0.21 | -0.84 | NA | Q3 2020 10/26/2020 | 6.20 | 0.02 | 0.08 | 77.5 | Q2 2020 7/27/2020 | 6.28 | -0.07 | -0.28 | NA | Q1 2020 5/4/2020 | 7.58 | 0.02 | 0.08 | 94.8 |
|
On this page we presented the MEDS PE Ratio History information for Trxade Health' stock.
The average MEDS PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 86.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MEDS PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.
Let's now compare this MEDS PE ratio history result, against the recent PE: when this page was posted on 11/7/2022, the most recent closing price for MEDS had been 0.83, and the most recent quarterly earnings result, annualized, was 0.08. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent MEDS PE on 11/7/2022 based on annualized quarterly EPS was 10.4. Based on MEDS's history, that recent PE is low relative to the historical average, with the recent PE 87.9% lower than the historical average PE across our data set for Trxade Health.
For self directed investors doing their due diligence on MEDS or any other given stock, valuation analysis for MEDS
can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can
help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios
justify the current stock market value.
That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate
Trxade Health PE ratio history — or the PE history for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for
next earnings dates and also historical earnings surprises history for MEDS. Thanks for visiting, and the next
time you need to research MEDS PE Ratio History or the PE ratio history for another stock, we hope our site
will come to mind as your go-to PE ratio history research resource of choice.